Please select the outcome measures that correspond to the clinical trial below.
Title: A Randomized Trail of Continues Methadone Maintenance Versus Detoxification in Jail
Brief Summary: Methadone maintenance treatment (MMT) has been shown to be effective in reducing drug use, criminal activity and recidivism. Given this effectiveness, maintaining individuals who are enrolled in community MMT when committed to the Department of Corrections for short term incarceration would improve post release outcomes. However, this is rarely practiced in the United States. Current practice at the Rhode Island Department of Corrections is to detox inmates on methadone within 30 days of being incarcerated. More than 75% of these individuals are incarcerated for less than six months. The period immediately after release from incarceration is a particularly high-risk time for HIV and other problems including drug relapse and overdose.

The investigators hypothesize that inmates who are incarcerated for 6 months or less will have better outcomes and cost the state less money if they are maintained on their methadone dose and relinked to their community clinic at release, than the current practice of detoxification.


Options:
A: A reduction in the use of drugs and alcohol (12 months)
B: Abstinence (3 month follow up); Abstinence (6 month follow up); Abstinence (9 month follow up); Abstinence (12 month follow up); Abstinence (18 month follow up); Abstinence (24 month follow up); Cocaine Urine Toxicology (3 month follow up); Cocaine Urine Toxicology (6 month follow up); Cocaine Urine Toxicology (9 month follow up); Cocaine Urine Toxicology (12 month follow up); Cocaine Urine Toxicology (18 month follow up); Cocaine Urine Toxicology (24 month follow up); Comparison Across Groups in Societal Costs (24 months); Net Saving/Spending Comparisons Across Groups From Provider Perspective (24 months); Net Comparisons of Savings and Spendings Across Groups From Societal Perspective (24 months); Percent Days Cocaine Use (3 months (approximately study days 1 - 90)); Percent Days Cocaine Use (6 months (approproximately study days 91 - 180)); Percent Days Cocaine Use (9 months (approximately study days 181 - 270)); Percent Days Cocaine Use (12 months (approximately study days 271 - 365)); Percent Days Cocaine Use (18 months (approximately study days 366 - 546)); Percent Days Cocaine Use (24 months (approximately study days 547 - 730)); Percent Days Abstinent (3 months (approximately study days 1 - 90)); Percent Days Abstinent (6 months (approximately study days 91 - 180)); Percent Days Abstinent (9 months (approximately study days 181 - 270)); Percent Days Abstinent (12 months (approximately study days 271 - 365)); Percent Days Abstinent (18 months (approximately days 366 - 546)); Percent Days Abstinent (24 months (approximately study days 547 - 730))
C: Graduation from juvenile drug court (Collected once at 12 months from intake/baseline.); Change in substance use (Baseline at the begining of the study, and then at 6, 12, 18, and 24 months after baseline); Change in delinquency (Baseline, and then at 6, 12, 18, and 24 months after baseline); Change in Mental health symptoms (Baseline, 6, 12, 18 and 24 months after baseline); Change in Family functioning (Baseline, 6, 14, 18, and 24 months after baseline); Length of treatment (Collected once, at 12 months after baseline); Change in arrests (12 months before intake through 24 months after intake); Change in substance use (Intake, 6, 12, 18, 24 months after intake); Change in substance use (Intake, 6, 12, 18 and 24 months after intake)
D: Time to post release treatment engagement (30 days post release); Reduction of HIV risk behaviors (12 months); Time to relapse (30 days post release); Cost effectiveness (12 months)

Answer: D